GSK and Vir, navigating early antibody pitfalls, tout delta variant-busting data for latecomer sotrovimab fkansteiner Tue, 06/29/2021 – 09:53 More: GSK and Vir, navigating early antibody pitfalls, tout delta variant-busting data for latecomer sotrovimab Source: fierce
read moreNovartis, GBT sickle cell drugs face coverage hurdles as gene therapy threats loom: survey aliu Tue, 06/29/2021 – 09:11 More: Novartis, GBT sickle cell drugs face coverage hurdles as gene therapy threats loom: survey Source: fierce
read moreSanofi is currently collaborating with Translate Bio on a mRNA-based COVID-19 vaccine candidate More: Sanofi plans €400m investment in mRNA vaccines ‘centre of excellence’ Source: News
read moreCompany initially withdrew a marketing authorisation application for the gene therapy last year More: BioMarin resubmits haemophilia A gene therapy to the EMA Source: News
read moreThe new Code has been updated to reflect changes in the pharma environment More: ABPI launches updated Code of Practice Source: News
read moreMixing different vaccines produces a strong immune response against virus, according to researchers More: ‘Mix and match’ COVID-19 vaccine study yields promising results Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals